ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. CCXI $25.6500 -1.1100 % -4.1500 Chemocentryx Inc […]
Read MoreThe Clorox Company (CLX) The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. Church & Dwight Co., Inc. (CHD) Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, […]
Read MoreHostess Brands, Inc. (TWNK) Hostess Brands, Inc., a packaged food company, develops, manufactures, markets, sells, and distributes snack products in the United States. The company provides a range of snack cakes, donuts, sweet rolls, breakfast pastries, and much more. Incyte Corporation (INCY) Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of […]
Read More(Bloomberg) — Oil futures dropped below $100 a barrel for the first time since May as concerns grow that a global economic slowdown will ultimately hobble demand. West Texas Intermediate crude futures dropped as much as 9.3% to near $98 a barrel. Oil was pressured in a low liquidity session on Tuesday as equities fell […]
Read MoreBuy Price: $32.55 or better Sell Price: TradersPro Sell Signal Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The stocks founds in the One Hot Stock category use stocks that are in long term, short term trends […]
Read More(Bloomberg) — Signs of a rapidly deteriorating US economic outlook have spurred bond traders to pencil in a complete policy turnaround by the Federal Reserve in the coming year, with interest-rate cuts in the middle of 2023. Fed Chair Jerome Powell — who is widely expected to keep lifting the central bank’s benchmark rate for […]
Read More“Uncertainty” has been a good way to describe market conditions throughout 2022. To compound the difficulty, few analysts and economists expect things to change for the rest of the year, which makes it harder for investors to decide to keep their money working for them. Inflation continues to remain high, despite three interest rate increases […]
Read More(Bloomberg) — The US economy is firmly in the middle of a slowdown that’s turning out to be worse than expected amid the war in Ukraine and China’s Covid Zero policy, according to Morgan Stanley strategists. With a recent dip in bond yields, investors are betting the Federal Reserve may turn less hawkish if inflation […]
Read More